 | • レポートコード：MRC2-11QY12057 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は神経膠腫（グリオーマ）診断・治療のグローバル市場について調査・分析したレポートです。種類別（診断（CT・MRI）、治療（手術・化学療法））市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別神経膠腫（グリオーマ）診断・治療の競争状況、市場シェア ・世界の神経膠腫（グリオーマ）診断・治療市場：種類別市場規模 2015年-2020年（診断（CT・MRI）、治療（手術・化学療法）） ・世界の神経膠腫（グリオーマ）診断・治療市場：種類別市場規模予測 2021年-2026年（診断（CT・MRI）、治療（手術・化学療法）） ・世界の神経膠腫（グリオーマ）診断・治療市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の神経膠腫（グリオーマ）診断・治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の神経膠腫（グリオーマ）診断・治療市場分析：米国、カナダ ・ヨーロッパの神経膠腫（グリオーマ）診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの神経膠腫（グリオーマ）診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の神経膠腫（グリオーマ）診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの神経膠腫（グリオーマ）診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Thermo Fisher Scientific、Emcure Pharmaceuticals、Sigma-Aldrich、Pfizer、Taj Pharmaceuticals、Novartis International、Teva Pharmaceutical、GE Healthcare、Siemens Healthcare、Philips Healthcare、Shimadzu Corporation、Canon Medical Systems、Merck、Roche、Arbor Pharmaceuticals、Sun Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A glioma is a type of tumor that originates in the brain and is also known as a primary brain tumor. There are numerous types of gliomas which are entitled based on the origin of the cell type including oligodendrogliomas, astrocytoma, ependymomas, and glioblastoma. Nearly 33 percent of all brain tumors are gliomas.
Astrocytoma is the most common types of glioma diagnosed worldwide, as more than 30% of all the diagnosed cases with brain tumors are astrocytoma. These types of tumors are not curable as they spread easily through normal brain tissue. The American Brain Tumor Association has evaluated that around 7% of all the primary brain tumors represent astrocytoma.
Market Analysis and Insights: Global Glioma Diagnosis and Treatment Market
The global Glioma Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Glioma Diagnosis and Treatment Scope and Market Size
Glioma Diagnosis and Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glioma Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Thermo Fisher Scientific
Emcure Pharmaceuticals
Sigma-Aldrich
Pfizer
Taj Pharmaceuticals
Novartis International
Teva Pharmaceutical
GE Healthcare
Siemens Healthcare
Philips Healthcare
Shimadzu Corporation
Canon Medical Systems
Merck
Roche
Arbor Pharmaceuticals
Sun Pharmaceutical
Market segment by Type, the product can be split into
Diagnosis (CT, MRI)
Treatment (Surgery, Chemotherapy)
Market segment by Application, split into
Hospitals
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Glioma Diagnosis and Treatment Revenue
1.4 Market by Type
1.4.1 Global Glioma Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnosis (CT, MRI)
1.4.3 Treatment (Surgery, Chemotherapy)
1.5 Market by Application
1.5.1 Global Glioma Diagnosis and Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Glioma Diagnosis and Treatment Market Perspective (2015-2026)
2.2 Global Glioma Diagnosis and Treatment Growth Trends by Regions
2.2.1 Glioma Diagnosis and Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Glioma Diagnosis and Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Glioma Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Glioma Diagnosis and Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Glioma Diagnosis and Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Glioma Diagnosis and Treatment Players by Market Size
3.1.1 Global Top Glioma Diagnosis and Treatment Players by Revenue (2015-2020)
3.1.2 Global Glioma Diagnosis and Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Glioma Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Glioma Diagnosis and Treatment Market Concentration Ratio
3.2.1 Global Glioma Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Glioma Diagnosis and Treatment Revenue in 2019
3.3 Glioma Diagnosis and Treatment Key Players Head office and Area Served
3.4 Key Players Glioma Diagnosis and Treatment Product Solution and Service
3.5 Date of Enter into Glioma Diagnosis and Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Glioma Diagnosis and Treatment Historic Market Size by Type (2015-2020)
4.2 Global Glioma Diagnosis and Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Glioma Diagnosis and Treatment Market Size by Application (2015-2020)
5.2 Global Glioma Diagnosis and Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Glioma Diagnosis and Treatment Market Size (2015-2020)
6.2 Glioma Diagnosis and Treatment Key Players in North America (2019-2020)
6.3 North America Glioma Diagnosis and Treatment Market Size by Type (2015-2020)
6.4 North America Glioma Diagnosis and Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Glioma Diagnosis and Treatment Market Size (2015-2020)
7.2 Glioma Diagnosis and Treatment Key Players in Europe (2019-2020)
7.3 Europe Glioma Diagnosis and Treatment Market Size by Type (2015-2020)
7.4 Europe Glioma Diagnosis and Treatment Market Size by Application (2015-2020)
8 China
8.1 China Glioma Diagnosis and Treatment Market Size (2015-2020)
8.2 Glioma Diagnosis and Treatment Key Players in China (2019-2020)
8.3 China Glioma Diagnosis and Treatment Market Size by Type (2015-2020)
8.4 China Glioma Diagnosis and Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Glioma Diagnosis and Treatment Market Size (2015-2020)
9.2 Glioma Diagnosis and Treatment Key Players in Japan (2019-2020)
9.3 Japan Glioma Diagnosis and Treatment Market Size by Type (2015-2020)
9.4 Japan Glioma Diagnosis and Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Glioma Diagnosis and Treatment Market Size (2015-2020)
10.2 Glioma Diagnosis and Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Glioma Diagnosis and Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Glioma Diagnosis and Treatment Market Size by Application (2015-2020)
11 India
11.1 India Glioma Diagnosis and Treatment Market Size (2015-2020)
11.2 Glioma Diagnosis and Treatment Key Players in India (2019-2020)
11.3 India Glioma Diagnosis and Treatment Market Size by Type (2015-2020)
11.4 India Glioma Diagnosis and Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Glioma Diagnosis and Treatment Market Size (2015-2020)
12.2 Glioma Diagnosis and Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Glioma Diagnosis and Treatment Market Size by Type (2015-2020)
12.4 Central & South America Glioma Diagnosis and Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Details
13.1.2 Thermo Fisher Scientific Business Overview
13.1.3 Thermo Fisher Scientific Glioma Diagnosis and Treatment Introduction
13.1.4 Thermo Fisher Scientific Revenue in Glioma Diagnosis and Treatment Business (2015-2020))
13.1.5 Thermo Fisher Scientific Recent Development
13.2 Emcure Pharmaceuticals
13.2.1 Emcure Pharmaceuticals Company Details
13.2.2 Emcure Pharmaceuticals Business Overview
13.2.3 Emcure Pharmaceuticals Glioma Diagnosis and Treatment Introduction
13.2.4 Emcure Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
13.2.5 Emcure Pharmaceuticals Recent Development
13.3 Sigma-Aldrich
13.3.1 Sigma-Aldrich Company Details
13.3.2 Sigma-Aldrich Business Overview
13.3.3 Sigma-Aldrich Glioma Diagnosis and Treatment Introduction
13.3.4 Sigma-Aldrich Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
13.3.5 Sigma-Aldrich Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Glioma Diagnosis and Treatment Introduction
13.4.4 Pfizer Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Taj Pharmaceuticals
13.5.1 Taj Pharmaceuticals Company Details
13.5.2 Taj Pharmaceuticals Business Overview
13.5.3 Taj Pharmaceuticals Glioma Diagnosis and Treatment Introduction
13.5.4 Taj Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
13.5.5 Taj Pharmaceuticals Recent Development
13.6 Novartis International
13.6.1 Novartis International Company Details
13.6.2 Novartis International Business Overview
13.6.3 Novartis International Glioma Diagnosis and Treatment Introduction
13.6.4 Novartis International Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
13.6.5 Novartis International Recent Development
13.7 Teva Pharmaceutical
13.7.1 Teva Pharmaceutical Company Details
13.7.2 Teva Pharmaceutical Business Overview
13.7.3 Teva Pharmaceutical Glioma Diagnosis and Treatment Introduction
13.7.4 Teva Pharmaceutical Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
13.7.5 Teva Pharmaceutical Recent Development
13.8 GE Healthcare
13.8.1 GE Healthcare Company Details
13.8.2 GE Healthcare Business Overview
13.8.3 GE Healthcare Glioma Diagnosis and Treatment Introduction
13.8.4 GE Healthcare Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
13.8.5 GE Healthcare Recent Development
13.9 Siemens Healthcare
13.9.1 Siemens Healthcare Company Details
13.9.2 Siemens Healthcare Business Overview
13.9.3 Siemens Healthcare Glioma Diagnosis and Treatment Introduction
13.9.4 Siemens Healthcare Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
13.9.5 Siemens Healthcare Recent Development
13.10 Philips Healthcare
13.10.1 Philips Healthcare Company Details
13.10.2 Philips Healthcare Business Overview
13.10.3 Philips Healthcare Glioma Diagnosis and Treatment Introduction
13.10.4 Philips Healthcare Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
13.10.5 Philips Healthcare Recent Development
13.11 Shimadzu Corporation
10.11.1 Shimadzu Corporation Company Details
10.11.2 Shimadzu Corporation Business Overview
10.11.3 Shimadzu Corporation Glioma Diagnosis and Treatment Introduction
10.11.4 Shimadzu Corporation Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
10.11.5 Shimadzu Corporation Recent Development
13.12 Canon Medical Systems
10.12.1 Canon Medical Systems Company Details
10.12.2 Canon Medical Systems Business Overview
10.12.3 Canon Medical Systems Glioma Diagnosis and Treatment Introduction
10.12.4 Canon Medical Systems Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
10.12.5 Canon Medical Systems Recent Development
13.13 Merck
10.13.1 Merck Company Details
10.13.2 Merck Business Overview
10.13.3 Merck Glioma Diagnosis and Treatment Introduction
10.13.4 Merck Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
10.13.5 Merck Recent Development
13.14 Roche
10.14.1 Roche Company Details
10.14.2 Roche Business Overview
10.14.3 Roche Glioma Diagnosis and Treatment Introduction
10.14.4 Roche Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
10.14.5 Roche Recent Development
13.15 Arbor Pharmaceuticals
10.15.1 Arbor Pharmaceuticals Company Details
10.15.2 Arbor Pharmaceuticals Business Overview
10.15.3 Arbor Pharmaceuticals Glioma Diagnosis and Treatment Introduction
10.15.4 Arbor Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
10.15.5 Arbor Pharmaceuticals Recent Development
13.16 Sun Pharmaceutical
10.16.1 Sun Pharmaceutical Company Details
10.16.2 Sun Pharmaceutical Business Overview
10.16.3 Sun Pharmaceutical Glioma Diagnosis and Treatment Introduction
10.16.4 Sun Pharmaceutical Revenue in Glioma Diagnosis and Treatment Business (2015-2020)
10.16.5 Sun Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Glioma Diagnosis and Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Glioma Diagnosis and Treatment Revenue
Table 3. Ranking of Global Top Glioma Diagnosis and Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Glioma Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnosis (CT, MRI)
Table 6. Key Players of Treatment (Surgery, Chemotherapy)
Table 7. Global Glioma Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Glioma Diagnosis and Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Glioma Diagnosis and Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Glioma Diagnosis and Treatment Market Share by Regions (2015-2020)
Table 11. Global Glioma Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Glioma Diagnosis and Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Glioma Diagnosis and Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Glioma Diagnosis and Treatment Players
Table 18. Global Glioma Diagnosis and Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Glioma Diagnosis and Treatment Market Share by Players (2015-2020)
Table 20. Global Top Glioma Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioma Diagnosis and Treatment as of 2019)
Table 21. Global Glioma Diagnosis and Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Glioma Diagnosis and Treatment Product Solution and Service
Table 24. Date of Enter into Glioma Diagnosis and Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Glioma Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Glioma Diagnosis and Treatment Market Size Share by Type (2015-2020)
Table 28. Global Glioma Diagnosis and Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Glioma Diagnosis and Treatment Market Size Share by Application (2015-2020)
Table 30. Global Glioma Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Glioma Diagnosis and Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Glioma Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Glioma Diagnosis and Treatment Market Share (2019-2020)
Table 34. North America Glioma Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Glioma Diagnosis and Treatment Market Share by Type (2015-2020)
Table 36. North America Glioma Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Glioma Diagnosis and Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Glioma Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Glioma Diagnosis and Treatment Market Share (2019-2020)
Table 40. Europe Glioma Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Glioma Diagnosis and Treatment Market Share by Type (2015-2020)
Table 42. Europe Glioma Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Glioma Diagnosis and Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Glioma Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Glioma Diagnosis and Treatment Market Share (2019-2020)
Table 46. China Glioma Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Glioma Diagnosis and Treatment Market Share by Type (2015-2020)
Table 48. China Glioma Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Glioma Diagnosis and Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Glioma Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Glioma Diagnosis and Treatment Market Share (2019-2020)
Table 52. Japan Glioma Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Glioma Diagnosis and Treatment Market Share by Type (2015-2020)
Table 54. Japan Glioma Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Glioma Diagnosis and Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Glioma Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Glioma Diagnosis and Treatment Market Share (2019-2020)
Table 58. Southeast Asia Glioma Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Glioma Diagnosis and Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Glioma Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Glioma Diagnosis and Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Glioma Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Glioma Diagnosis and Treatment Market Share (2019-2020)
Table 64. India Glioma Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Glioma Diagnosis and Treatment Market Share by Type (2015-2020)
Table 66. India Glioma Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Glioma Diagnosis and Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Glioma Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Glioma Diagnosis and Treatment Market Share (2019-2020)
Table 70. Central & South America Glioma Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Glioma Diagnosis and Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Glioma Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Glioma Diagnosis and Treatment Market Share by Application (2015-2020)
Table 74. Thermo Fisher Scientific Company Details
Table 75. Thermo Fisher Scientific Business Overview
Table 76. Thermo Fisher Scientific Product
Table 77. Thermo Fisher Scientific Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 78. Thermo Fisher Scientific Recent Development
Table 79. Emcure Pharmaceuticals Company Details
Table 80. Emcure Pharmaceuticals Business Overview
Table 81. Emcure Pharmaceuticals Product
Table 82. Emcure Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 83. Emcure Pharmaceuticals Recent Development
Table 84. Sigma-Aldrich Company Details
Table 85. Sigma-Aldrich Business Overview
Table 86. Sigma-Aldrich Product
Table 87. Sigma-Aldrich Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 88. Sigma-Aldrich Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Taj Pharmaceuticals Company Details
Table 95. Taj Pharmaceuticals Business Overview
Table 96. Taj Pharmaceuticals Product
Table 97. Taj Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 98. Taj Pharmaceuticals Recent Development
Table 99. Novartis International Company Details
Table 100. Novartis International Business Overview
Table 101. Novartis International Product
Table 102. Novartis International Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 103. Novartis International Recent Development
Table 104. Teva Pharmaceutical Company Details
Table 105. Teva Pharmaceutical Business Overview
Table 106. Teva Pharmaceutical Product
Table 107. Teva Pharmaceutical Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 108. Teva Pharmaceutical Recent Development
Table 109. GE Healthcare Business Overview
Table 110. GE Healthcare Product
Table 111. GE Healthcare Company Details
Table 112. GE Healthcare Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 113. GE Healthcare Recent Development
Table 114. Siemens Healthcare Company Details
Table 115. Siemens Healthcare Business Overview
Table 116. Siemens Healthcare Product
Table 117. Siemens Healthcare Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 118. Siemens Healthcare Recent Development
Table 119. Philips Healthcare Company Details
Table 120. Philips Healthcare Business Overview
Table 121. Philips Healthcare Product
Table 122. Philips Healthcare Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 123. Philips Healthcare Recent Development
Table 124. Shimadzu Corporation Company Details
Table 125. Shimadzu Corporation Business Overview
Table 126. Shimadzu Corporation Product
Table 127. Shimadzu Corporation Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 128. Shimadzu Corporation Recent Development
Table 129. Canon Medical Systems Company Details
Table 130. Canon Medical Systems Business Overview
Table 131. Canon Medical Systems Product
Table 132. Canon Medical Systems Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 133. Canon Medical Systems Recent Development
Table 134. Merck Company Details
Table 135. Merck Business Overview
Table 136. Merck Product
Table 137. Merck Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 138. Merck Recent Development
Table 139. Roche Company Details
Table 140. Roche Business Overview
Table 141. Roche Product
Table 142. Roche Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 143. Roche Recent Development
Table 144. Arbor Pharmaceuticals Company Details
Table 145. Arbor Pharmaceuticals Business Overview
Table 146. Arbor Pharmaceuticals Product
Table 147. Arbor Pharmaceuticals Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 148. Arbor Pharmaceuticals Recent Development
Table 149. Sun Pharmaceutical Company Details
Table 150. Sun Pharmaceutical Business Overview
Table 151. Sun Pharmaceutical Product
Table 152. Sun Pharmaceutical Revenue in Glioma Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 153. Sun Pharmaceutical Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glioma Diagnosis and Treatment Market Share by Type: 2020 VS 2026
Figure 2. Diagnosis (CT, MRI) Features
Figure 3. Treatment (Surgery, Chemotherapy) Features
Figure 4. Global Glioma Diagnosis and Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Glioma Diagnosis and Treatment Report Years Considered
Figure 8. Global Glioma Diagnosis and Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Glioma Diagnosis and Treatment Market Share by Regions: 2020 VS 2026
Figure 10. Global Glioma Diagnosis and Treatment Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Glioma Diagnosis and Treatment Market Share by Players in 2019
Figure 13. Global Top Glioma Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioma Diagnosis and Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Glioma Diagnosis and Treatment Revenue in 2019
Figure 15. North America Glioma Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Glioma Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Glioma Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Glioma Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Glioma Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Glioma Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Glioma Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
癲癇診断・治療の世界市場（～2026年） Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the …- 髄膜炎診断・治療の世界市場（～2026年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …
- HIV診断・治療の世界市場（～2026年） HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is l…
- ミトコンドリアミオパチー診断・治療の世界市場（～2026年） Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate "ragged red" muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an incr…
- 十字靭帯診断・治療の世界市場（～2026年） A ligament is a band of tissue that holds the bones together, keeping the knee stable. Primarily these ligaments are broadly classified into cruciate ligament and collateral ligament. Further, these are divided into four primary ligaments, namely, Anterior Cruciate Ligament (ACL), Posterior Cruciate…